Publications by Marius Trøseid

182 publications found

Publications 2025

1. Mikaeloff F, Gelpi M, Escós A, Wang T, Gupta S, Olofsson A, Akusjärvi SS, Schuster S, Naval P, Sood V, Nikouyan N, Knudsen AD, Vestad B, Høgh J, Hov JR, Benfield T, Trøseid M, Pawar V, Rucevic M, Benfeitas R, Végvári Á, O'Mahony L, Savai R, Björkström NK, Lourda M et al. (2025)
   Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission Ex Vivo
   Adv Sci (Weinh), e2416453 (in press)
   DOI 10.1002/advs.202416453, PubMed 40013867
2. Suarez-Zdunek MA, Knudsen AD, Fuchs A, Kirkby NS, Benfield T, Gerstoft J, Trøseid M, Ostrowski SR, Køber LV, Kofoed KF, Nielsen SD (2025)
   Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort Study
   Viruses, 17 (2)
   DOI 10.3390/v17020231, PubMed 40006986

Publications 2024

1. Bai X, Nielsen SD, Kunisaki KM, Trøseid M (2024)
   Pulmonary comorbidities in people with HIV- the microbiome connection
   Curr Opin HIV AIDS, 19 (5), 246-252
   DOI 10.1097/COH.0000000000000871, PubMed 38935049
2. Barratt-Due A, Pettersen K, Børresdatter-Dahl T, Holter JC, Grønli RH, Dyrhol-Riise AM, Lerum TV, Holten AR, Tonby K, Trøseid M, Skjønsberg OH, Granerud BK, Heggelund L, Kildal AB, Schjalm C, Aaløkken TM, Aukrust P, Ueland T, Mollnes TE, Halvorsen B, NOR‐Solidarity study groupThe Norwegian SARS‐CoV‐2 study group (2024)
   Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients
   J Intern Med, 296 (1), 80-92
   DOI 10.1111/joim.13783, PubMed 38539241
3. Bratseth V, Nendl A, Raju SC, Holm K, Broch K, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2024)
   Gut dysbiosis and neutrophil extracellular traps in chronic heart failure
   Int J Cardiol, 419, 132689
   DOI 10.1016/j.ijcard.2024.132689, PubMed 39489348
4. De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T (2024)
   Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
   Int J Cardiol, 400, 131809
   DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129
5. Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I (2024)
   IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement
   J Infect, 89 (1), 106176
   DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
6. Hites M, Massonnaud CR, Lapique EL, Belhadi D, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Moing VL, Piroth L, Sellier P et al. (2024)
   Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
   J Infect, 88 (3), 106120
   DOI 10.1016/j.jinf.2024.106120, PubMed 38367705
7. Hoel H, Dahl TB, Yang K, Skeie LG, Michelsen AE, Ueland T, Damås JK, Dyrhol-Riise AM, Fevang B, Yndestad A, Aukrust P, Trøseid M, Sandanger Ø (2024)
   Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release
   Int J Mol Sci, 25 (13)
   DOI 10.3390/ijms25137141, PubMed 39000248
8. Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2024)
   Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
   Sci Rep, 14 (1), 3704
   DOI 10.1038/s41598-024-54117-6, PubMed 38355714
9. Murphy SL, Balzer NR, Ranheim T, Sagen EL, Huse C, Bjerkeli V, Michelsen AE, Finbråten AK, Heggelund L, Dyrhol-Riise AM, Tveita A, Holten AR, Trøseid M, Ueland T, Ulas T, Aukrust P, Barratt-Due A, Halvorsen B, Dahl TB (2024)
   Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study
   Front Immunol, 15, 1379570
   DOI 10.3389/fimmu.2024.1379570, PubMed 38957465
10. Nendl A, Andersen GØ, Seljeflot I, Trøseid M, Awoyemi A (2024)
    Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction
    Open Heart, 11 (2)
    DOI 10.1136/openhrt-2024-002868, PubMed 39277188
11. Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
    The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
    Commun Med (Lond), 4 (1), 231
    DOI 10.1038/s43856-024-00650-4, PubMed 39533001
12. Patrick-Brown TDJH, Bourner J, Kali S, Trøseid M, Yazdanpanah Y, Olliaro P, Olsen IC (2024)
    Experiences and challenges with the new European Clinical Trials Regulation
    Trials, 25 (1), 3
    DOI 10.1186/s13063-023-07869-x, PubMed 38167484
13. Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
    Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
    Genome Med, 16 (1), 27
    DOI 10.1186/s13073-024-01296-6, PubMed 38331891
14. Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, Cabello-Ubeda A, Sendagorta E, Kurz A, Perez Molina JA, de Benito A, Hov JR, Fernandez-Lopez L, Muriel A, Del Campo R, Moreno S, Trøseid M, Seifert J, Ferrer M (2024)
    Author Correction: Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer
    Nat Med, 30 (1), 303
    DOI 10.1038/s41591-023-02529-8, PubMed 37587221
15. Trøseid M (2024)
    Viral, Host Factors or Both as COVID-19 Biomarkers
    Clin Infect Dis, 78 (6), 1504-1505
    DOI 10.1093/cid/ciad779, PubMed 38376208
16. Trøseid M, Molinaro A, Gelpi M, Vestad B, Kofoed KF, Fuchs A, Køber L, Holm K, Benfield T, Ueland PM, Hov JR, Nielsen SD, Knudsen AD (2024)
    Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV
    J Infect Dis, 229 (3), 898-907
    DOI 10.1093/infdis/jiad604, PubMed 38195204
17. Trøseid M, Nielsen SD, Vujkovic-Cvijin I (2024)
    Gut microbiome and cardiometabolic comorbidities in people living with HIV
    Microbiome, 12 (1), 106
    DOI 10.1186/s40168-024-01815-y, PubMed 38877521
18. Ueland T, Nkele I, Hoel H, Lockman S, Michelsen AE, Moshomo T, Aukrust P, Mohammed T, Trøseid M, Mosepele M (2024)
    Markers of extracellular matrix degradation and inflammasome activation are associated with carotid plaques in virally suppressed people with HIV in Botswana
    AIDS, 39 (1), 22-30
    DOI 10.1097/QAD.0000000000004014, PubMed 39283741
19. Viermyr HK, Halvorsen B, Sagen EL, Michelsen AE, Barrat-Due A, Kåsine T, Nezvalova-Henriksen K, Dyrhol-Riise AM, Nor‐Solidarity Consortium, Lerum TV, Müller F, Tonby K, Tveita A, Aukrust P, Trøseid M, Ueland T, Dahl TB (2024)
    High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 296 (3), 249-259
    DOI 10.1111/joim.13820, PubMed 39011800
20. Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy D et al. (2024)
    Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
    EBioMedicine, 111, 105511
    DOI 10.1016/j.ebiom.2024.105511, PubMed 39731852

Publications 2023

1. Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
   Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
   J Hepatol, 79 (4), 955-966
   DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
2. Juul FE, Hov JER, Trøseid M, Johnsen PH, Valeur J (2023)
   [Gut microbiota and intestinal disease –a sober warning]
   Tidsskr Nor Laegeforen, 143 (10)
   DOI 10.4045/tidsskr.23.0121, PubMed 37376933
3. Knudsen AD, Eskelund CW, Benfield T, Zhao Y, Gelpi M, Køber L, Trøseid M, Kofoed KF, Ostrowski SR, Reilly C, Borges ÁH, Grønbæk K, Nielsen SD (2023)
   Clonal hematopoiesis of indeterminate potential in persons with HIV
   AIDS, 38 (4), 487-495
   DOI 10.1097/QAD.0000000000003788, PubMed 37976039
4. Knudsen AD, Fuchs A, Benfield T, Gerstoft J, Køber L, Trøseid M, Kofoed KF, Nielsen SD (2023)
   Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication
   Open Forum Infect Dis, 10 (7), ofad298
   DOI 10.1093/ofid/ofad298, PubMed 37441354
5. Mikaeloff F, Gelpi M, Benfeitas R, Knudsen AD, Vestad B, Høgh J, Hov JR, Benfield T, Murray D, Giske CG, Mardinoglu A, Trøseid M, Nielsen SD, Neogi U (2023)
   Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
   Elife, 12
   DOI 10.7554/eLife.82785, PubMed 36794912
6. Moreno E, Trøseid M, Vujkovic-Cvijin I, Marchetti G, Martín-Pedraza L, Serrano-Villar S (2023)
   Editorial: Targeting the microbiota to attenuate chronic inflammation
   Front Immunol, 14, 1202222
   DOI 10.3389/fimmu.2023.1202222, PubMed 37153550
7. Murphy SL, Halvorsen B, Holter JC, Huse C, Tveita A, Trøseid M, Hoel H, Kildal AB, Holten AR, Lerum TV, Skjønsberg OH, Michelsen AE, Aaløkken TM, NOR-SOLIDARITY Consortium, The Norwegian SARS-CoV-2 study group investigators, Tonby K, Lind A, Dudman S, Granerud BK, Heggelund L, Bøe S, Dyrholt-Riise AM, Aukrust P, Barratt-Due A, Ueland T, Dahl TB (2023)
   Circulating markers of extracellular matrix remodelling in severe COVID-19 patients
   J Intern Med, 294 (6), 784-797
   DOI 10.1111/joim.13725, PubMed 37718572
8. Nendl A, Raju SC, Broch K, Mayerhofer CCK, Holm K, Halvorsen B, Lappegård KT, Moscavitch S, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2023)
   Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
   Front Cardiovasc Med, 10, 1160030
   DOI 10.3389/fcvm.2023.1160030, PubMed 37332580
9. Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, Cabello-Ubeda A, Sendagorta E, Kurz A, Perez Molina JA, de Benito A, Hov JR, Fernandez-Lopez L, Muriel A, Del Campo R, Moreno S, Trøseid M, Seifert J, Ferrer M (2023)
   Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer
   Nat Med, 29 (7), 1738-1749
   DOI 10.1038/s41591-023-02407-3, PubMed 37464040
10. Terzić V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Trøseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentré F, Espérou H, Costagliola D, Røttingen JA, Poissy J, Rozé JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA et al. (2023)
    Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia
    Br J Clin Pharmacol, 89 (4), 1318-1328
    DOI 10.1111/bcp.15669, PubMed 36680782
11. Thudium RF, Arentoft NS, Hoel H, Afzal S, von Stemann JH, Forman JL, Wilcke JT, Benfield T, Trøseid M, Borges ÁH, Ostrowski SR, Vestbo J, Kunisaki KM, Jensen JS, Nielsen SD (2023)
    Elevated Levels of Interleukin-1β and Interleukin-10 Are Associated With Faster Lung Function Decline in People With Well-Treated Human Immunodeficiency Virus
    J Infect Dis, 228 (8), 1080-1088
    DOI 10.1093/infdis/jiad233, PubMed 37366576
12. Trøseid M, Arribas JR (2023)
    Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection
    Clin Microbiol Infect, 29 (4), 419-421
    DOI 10.1016/j.cmi.2023.01.006, PubMed 36641054
13. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
14. Trøseid M, Holter JC, Holm K, Vestad B, Sazonova T, Granerud BK, Dyrhol-Riise AM, Holten AR, Tonby K, Kildal AB, Heggelund L, Tveita A, Bøe S, Müller KE, Jenum S, Hov JR, Ueland T, Norwegian SARS-CoV-2 study group (2023)
    Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
    Crit Care, 27 (1), 69
    DOI 10.1186/s13054-023-04356-2, PubMed 36814280
15. Ueland T, Michelsen AE, Tveita AA, Kåsine T, Dahl TB, Finbråten AK, Holten AR, Skjønsberg OH, Mathiessen A, Henriksen KN, Trøseid M, Aaløkken TM, Halvorsen B, Dyrhol-Riise AM, Barratt-Due A, Aukrust P (2023)
    Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
    Res Pract Thromb Haemost, 8 (1), 102289
    DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
16. Ueland T, Waagsbø B, Berge RK, Trøseid M, Aukrust P, Damås JK (2023)
    Fatty Acids Composition and HIV Infection: Altered Levels of n-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression
    Viruses, 15 (7)
    DOI 10.3390/v15071613, PubMed 37515299
17. Ueland T, Äikäs LAO, Dahl TB, Gregersen I, Olsen MB, Michelsen A, Schanke Y, Holopainen M, Ruhanen H, Singh S, NOR-SOLIDARITY Consortium, Tveita AA, Finbråten AK, Heggelund L, Trøseid M, Dyrhol-Riise AM, Nyman TA, Holven KB, Öörni K, Aukrust P, Halvorsen B (2023)
    Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization
    J Infect, 86 (5), 489-492
    DOI 10.1016/j.jinf.2023.02.024, PubMed 36822413

Publications 2022

1. Aune SK, Bonnevie-Svendsen M, Nyborg C, Trøseid M, Seljeflot I, Hisdal J, Helseth R (2022)
   Gut Leakage and Cardiac Biomarkers after Prolonged Strenuous Exercise
   Med Sci Sports Exerc, 54 (9), 1476-1482
   DOI 10.1249/MSS.0000000000002948, PubMed 35482788
2. Awoyemi A, Hov JR, Trøseid M (2022)
   Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
   Circ Heart Fail, 16 (1), e010222
   DOI 10.1161/CIRCHEARTFAILURE.122.010222, PubMed 36524473
3. Gelpi M, Vestad B, Raju SC, Hansen SH, Høgh J, Midttun Ø, Ueland PM, Ueland T, Benfield T, Kofoed KF, Hov JR, Trøseid M, Nielsen SD (2022)
   Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation
   J Infect Dis, 225 (11), 1948-1954
   DOI 10.1093/infdis/jiac018, PubMed 35089326
4. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
   CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
   J Infect, 85 (6), 702-769
   DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
5. Hentzien M, Owen A, Strub-Wourgaft N, Pérez-Casas C, Trøseid M, Calmy A (2022)
   Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
   Front Microbiol, 13, 998287
   DOI 10.3389/fmicb.2022.998287, PubMed 36312942
6. Knudsen AD, Bouazzi R, Afzal S, Gelpi M, Benfield T, Høgh J, Thomsen MT, Trøseid M, Nordestgaard BG, Nielsen SD (2022)
   Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls
   BMC Infect Dis, 22 (1), 451
   DOI 10.1186/s12879-022-07450-y, PubMed 35546661
7. Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
   Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
   J Infect Dis, 225 (4), 661-674
   DOI 10.1093/infdis/jiaa714, PubMed 33216130
8. Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
   Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
   J Acquir Immune Defic Syndr, 89 (1), 77-86
   DOI 10.1097/QAI.0000000000002817, PubMed 34878437
9. Murphy SL, Halvorsen B, Barratt-Due A, Dyrhol-Riise AM, Aukrust P, Trøseid M, Dahl TB (2022)
   Remdesivir modifies interferon response in hospitalized COVID-19 patients
   J Infect, 85 (5), 573-607
   DOI 10.1016/j.jinf.2022.07.021, PubMed 35914611
10. Storm-Larsen C, Hande LN, Kummen M, Thunhaug H, Vestad B, Hansen SH, Hovland A, Trøseid M, Lappegård KT, Hov JR (2022)
    Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial
    Scand J Clin Lab Invest, 82 (5), 363-370
    DOI 10.1080/00365513.2022.2102540, PubMed 35913798
11. Stø K, Valeur J, Ueland T, Malmstrøm GH, Bjerkeli V, Trøseid M, Hov JR, Holm K, Vestad B, Halvorsen B, Skjelland M, Skagen KR (2022)
    Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis
    Sci Rep, 12 (1), 22378
    DOI 10.1038/s41598-022-26759-x, PubMed 36572703
12. Suarez-Zdunek MA, Høgh J, Kirkegaard-Klitbo DM, Jensen AMR, Rupert A, Trøseid M, Gerstoft J, Nielsen SD, Knudsen AD (2022)
    High incidence of subclinical peripheral artery disease in people with HIV
    AIDS, 36 (10), 1355-1362
    DOI 10.1097/QAD.0000000000003252, PubMed 35608109
13. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
14. Trøseid M, Diallo A, Hites M, Røttingen JA, Yazdanpanah Y (2022)
    Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
    Clin Microbiol Infect, 28 (5), 743-744
    DOI 10.1016/j.cmi.2021.12.014, PubMed 35031489
15. Trøseid M, Hentzien M, Ader F, Cardoso SW, Arribas JR, Molina JM, Mueller N, Hites M, Bonnet F, Manuel O, Costagliola D, Grinsztejn B, Olsen IC, Yazdapanah Y, Calmy A, EU RESPONSE, COMBINE (2022)
    Immunocompromised patients have been neglected in COVID-19 trials: a call for action
    Clin Microbiol Infect, 28 (9), 1182-1183
    DOI 10.1016/j.cmi.2022.05.005, PubMed 35623577
16. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699
17. Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L et al. (2022)
    Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
    J Intern Med, 291 (6), 801-812
    DOI 10.1111/joim.13458, PubMed 35212063

Publications 2021

1. Aune SK, Byrkjeland R, Solheim S, Arnesen H, Trøseid M, Awoyemi A, Seljeflot I, Helseth R (2021)
   Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
   Diabetol Metab Syndr, 13 (1), 36
   DOI 10.1186/s13098-021-00655-2, PubMed 33794977
2. Aune SK, Cwikiel J, Flaa A, Arnesen H, Solheim S, Awoyemi A, Trøseid M, Seljeflot I, Helseth R (2021)
   Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
   Cells, 10 (9)
   DOI 10.3390/cells10092193, PubMed 34571843
3. Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
   Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
   EBioMedicine, 70, 103511
   DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
4. Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB et al. (2021)
   Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
   Ann Intern Med, 174 (9), 1261-1269
   DOI 10.7326/M21-0653, PubMed 34251903
5. Dhillon AK, Rupp C, Bergquist A, Voitl R, Folseraas T, Trøseid M, Midttun Ø, Ueland PM, Karlsen TH, Vesterhus M, Kummen M, Hov JR (2021)
   Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis
   Scand J Gastroenterol, 56 (4), 443-452
   DOI 10.1080/00365521.2021.1880627, PubMed 33583308
6. Drivsholm N, Knudsen AD, Faurholt-Jepsen M, Midttun Ø, Trøseid M, Kirkegaard-Klitbo DM, Ueland PM, Nielsen SD, Gelpi M (2021)
   Alterations in the Kynurenine Pathway of Tryptophan Metabolism Are Associated With Depression in People Living With HIV
   J Acquir Immune Defic Syndr, 87 (2), e177-e181
   DOI 10.1097/QAI.0000000000002664, PubMed 33633032
7. EU-Response investigators group, Diallo A, Trøseid M, Simensen VC, Boston A, Demotes J, Olsen IC, Chung F, Paiva JA, Hites M, Ader F, Arribas JR, Baratt-Due A, Melien Ø, Tacconelli E, Staub T, Greil R, Tsiodras S, Briel M, Esperou H, Mentré F, Eustace J, Saillard J, Delmas C, LeMestre S et al. (2021)
   Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
   Clin Microbiol Infect, 28 (1), 1-5
   DOI 10.1016/j.cmi.2021.10.011, PubMed 34763056
8. Hustad NB, Degerud HM, Hjelmerud I, Fraz MSA, Nordøy I, Trøseid M, Fevang B, Aukrust P, Jørgensen SF (2021)
   Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule
   Front Immunol, 12, 670547
   DOI 10.3389/fimmu.2021.670547, PubMed 34012453
9. Ianevski A, Yao R, Zusinaite E, Lello LS, Wang S, Jo E, Yang J, Ravlo E, Wang W, Lysvand H, Løseth K, Oksenych V, Tenson T, Windisch MP, Poranen MM, Nieminen AI, Nordbø SA, Fenstad MH, Grødeland G, Aukrust P, Trøseid M, Kantele A, Lastauskienė E, Vitkauskienė A, Legrand N et al. (2021)
   Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
   Viruses, 13 (12)
   DOI 10.3390/v13122489, PubMed 34960758
10. Kåsine T, Dyrhol-Riise AM, Barratt-Due A, Kildal AB, Olsen IC, Nezvalova-Henriksen K, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Berg Å, Johannessen A, Heggelund L, Dahl TB, Halvorsen B, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR et al. (2021)
    Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 291 (2), 241-243
    DOI 10.1111/joim.13377, PubMed 34411368
11. Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
    Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
    Sci Rep, 11 (1), 23205
    DOI 10.1038/s41598-021-02547-x, PubMed 34853380
12. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
13. Thudium RF, Knudsen AD, Von Stemann JH, Hove-Skovsgaard M, Hoel H, Mocroft A, Reekie J, Ronit A, Gerstoft J, Vestbo J, Trøseid M, Borges ÁH, Ostrowski SR, Nielsen SD (2021)
    Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus
    J Infect Dis, 223 (10), 1690-1698
    DOI 10.1093/infdis/jiaa600, PubMed 33141877
14. Thudium RF, Ringheim H, Ronit A, Hoel H, Benfield T, Mocroft A, Gerstoft J, Trøseid M, Borges ÁH, Ostrowski SR, Vestbo J, Nielsen SD (2021)
    Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIV
    Front Immunol, 12, 668113
    DOI 10.3389/fimmu.2021.668113, PubMed 33936110
15. Troseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y (2021)
    Assessing the evidence on remdesivir
    Lancet Infect. Dis., 21 (12), 1630-1631
16. Trøseid M, Hites M, Barratt-Due A, Ader F, Yazdanpanah Y (2021)
    Assessing the evidence on remdesivir
    Lancet Infect Dis, 21 (12), 1630-1631
    DOI 10.1016/S1473-3099(21)00695-2, PubMed 34838222
17. Vestad B, Nyman TA, Hove-Skovsgaard M, Stensland M, Hoel H, Trøseid AS, Aspelin T, Aass HCD, Puhka M, Hov JR, Nielsen SD, Øvstebø R, Trøseid M (2021)
    Plasma extracellular vesicles in people living with HIV and type 2 diabetes are related to microbial translocation and cardiovascular risk
    Sci Rep, 11 (1), 21936
    DOI 10.1038/s41598-021-01334-y, PubMed 34754007

Publications 2020

1. Fretheim H, Chung BK, Didriksen H, Bækkevold ES, Midtvedt Ø, Brunborg C, Holm K, Valeur J, Tennøe AH, Garen T, Midtvedt T, Trøseid M, Zarè H, Lund MB, Hov JR, Lundin KEA, Molberg Ø, Hoffmann-Vold AM (2020)
   Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
   PLoS One, 15 (5), e0232739
   DOI 10.1371/journal.pone.0232739, PubMed 32437393
2. Gelpi M, Ueland PM, Trøseid M, Mocroft A, Lebech AM, Ullum H, Midttun Ø, Lundgren J, Nielsen SD (2020)
   Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus
   J Infect Dis, 221 (3), 419-427
   DOI 10.1093/infdis/jiz465, PubMed 31538186
3. Gelpi M, Vestad B, Hansen SH, Holm K, Drivsholm N, Goetz A, Kirkby NS, Lindegaard B, Lebech AM, Hoel H, Michelsen AE, Ueland T, Gerstoft J, Lundgren J, Hov JR, Nielsen SD, Trøseid M (2020)
   Impact of Human Immunodeficiency Virus-Related Gut Microbiota Alterations on Metabolic Comorbid Conditions
   Clin Infect Dis, 71 (8), e359-e367
   DOI 10.1093/cid/ciz1235, PubMed 31894240
4. Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, Otterdal K, Muller KE, Lind A, Muller F, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC, Trøseid M (2020)
   Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
   J Intern Med, 289 (4), 523-531
   DOI 10.1111/joim.13178, PubMed 32976665
5. Hoel H, Ueland T, Hove-Skovsgaard M, Hartling HJ, Gelpi M, Benfield T, Ullum H, Michelsen AE, Aukrust P, Nielsen SD, Trøseid M (2020)
   Soluble T-Cell Immunoglobulin Mucin Domain-3 Is Associated With Hepatitis C Virus Coinfection and Low-Grade Inflammation During Chronic Human Immunodeficiency Virus Infection
   Open Forum Infect Dis, 7 (2), ofaa033
   DOI 10.1093/ofid/ofaa033, PubMed 32055642
6. Hoel H, Ueland T, Knudsen A, Kjær A, Michelsen AE, Sagen EL, Halvorsen B, Yndestad A, Nielsen SD, Aukrust P, Lebech AM, Trøseid M (2020)
   Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals
   J Infect Dis, 221 (4), 506-509
   DOI 10.1093/infdis/jiz253, PubMed 31077280
7. Hove-Skovsgaard M, Abildgaard J, Gelpi M, Gaardbo JC, Kolte L, Ullum H, Trøseid M, Lindegaard B, Nielsen SD (2020)
   No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers
   BMC Infect Dis, 20 (1), 882
   DOI 10.1186/s12879-020-05594-3, PubMed 33238950
8. Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
   Rosuvastatin alters the genetic composition of the human gut microbiome
   Sci Rep, 10 (1), 5397
   DOI 10.1038/s41598-020-62261-y, PubMed 32214138
9. Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, Liwinski T, Zenouzi R, Storm-Larsen C, Midttun Ø, McCann A, Ueland PM, Høivik ML, Vesterhus M, Trøseid M, Laudes M, Lieb W, Karlsen TH, Bang C, Schramm C, Franke A, Hov JR (2020)
   Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
   Gastroenterology, 160 (5), 1784-1798.e0
   DOI 10.1053/j.gastro.2020.12.058, PubMed 33387530
10. Macpherson ME, Hov JR, Ueland T, Dahl TB, Kummen M, Otterdal K, Holm K, Berge RK, Mollnes TE, Trøseid M, Halvorsen B, Aukrust P, Fevang B, Jørgensen SF (2020)
    Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
    Front Immunol, 11, 574500
    DOI 10.3389/fimmu.2020.574500, PubMed 33042155
11. Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
    Low fibre intake is associated with gut microbiota alterations in chronic heart failure
    ESC Heart Fail, 7 (2), 456-466
    DOI 10.1002/ehf2.12596, PubMed 31978943
12. Nordøy I, Fraz MAS, Trøseid M, Fevang B, Aukrust P (2020)
    [Elevated serum ferritin is not only a sign of liver failure]
    Tidsskr Nor Laegeforen, 140 (8)
    DOI 10.4045/tidsskr.20.0376, PubMed 32463199
13. Reikvam DH, Meyer-Myklestad MH, Trøseid M, Stiksrud B (2020)
    Probiotics to manage inflammation in HIV infection
    Curr Opin Infect Dis, 33 (1), 34-43
    DOI 10.1097/QCO.0000000000000612, PubMed 31789692
14. Trøseid M (2020)
    [When COVID-19 meets the African health service]
    Tidsskr Nor Laegeforen, 140 (7)
    DOI 10.4045/tidsskr.20.0283, PubMed 32378852
15. Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
    EBioMedicine, 52, 102649
    DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
16. Trøseid M, Lutro O, Ormaasen V (2020)
    [Experimental treatment for COVID-19 should be undertaken in randomised studies]
    Tidsskr Nor Laegeforen, 140 (7)
    DOI 10.4045/tidsskr.20.0282, PubMed 32378863

Publications 2019

1. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
   Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
   Atherosclerosis, 286, 53-59
   DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620
2. Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2019)
   Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
   Sci Rep, 9 (1), 167 (Retracted)
   DOI 10.1038/s41598-018-35367-7, PubMed 30655568
3. Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
   Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
   ESC Heart Fail, 6 (3), 557-558
   DOI 10.1002/ehf2.12437, PubMed 31034162
4. Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
   Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
   AIDS, 33 (7), 1117-1129
   DOI 10.1097/QAD.0000000000002173, PubMed 30789356
5. Storm-Larsen C, Stiksrud B, Eriksen C, Nowak P, Holm K, Thalme A, Dyrhol-Riise AM, Brix S, Hov JR, Trøseid M (2019)
   Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals
   AIDS, 33 (4), 645-653
   DOI 10.1097/QAD.0000000000002087, PubMed 30531315
6. Troseid M (2019)
   Bone Marrow Transplantation - a cure for HIV?
   Tidsskr. Nor. Laegeforen., 139 (7), 580
7. Trøseid M (2019)
   [Bone marrow transplantation – a cure for HIV?]
   Tidsskr Nor Laegeforen, 139 (7)
   DOI 10.4045/tidsskr.19.0199, PubMed 30969050
8. Trøseid M, Mayerhofer CCK, Broch K, Arora S, Svardal A, Hov JR, Andreassen AK, Gude E, Karason K, Dellgren G, Berge RK, Gullestad L, Aukrust P, Ueland T (2019)
   The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection
   J Heart Lung Transplant, 38 (10), 1097-1103
   DOI 10.1016/j.healun.2019.06.003, PubMed 31301965

Publications 2018

1. Arnbjerg CJ, Vestad B, Hov JR, Pedersen KK, Jespersen S, Johannesen HH, Holm K, Halvorsen B, Fallentin E, Hansen AE, Lange T, Kjær A, Trøseid M, Fischer BM, Nielsen SD (2018)
   Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals
   J Acquir Immune Defic Syndr, 78 (4), 450-457
   DOI 10.1097/QAI.0000000000001693, PubMed 29874201
2. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
   Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
   Diabetol Metab Syndr, 10, 59
   DOI 10.1186/s13098-018-0360-3, PubMed 30038669
3. Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
   Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
   Liver Int, 39 (2), 371-381
   DOI 10.1111/liv.13979, PubMed 30269440
4. Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
   Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
   Sci Rep, 8 (1), 6725
   DOI 10.1038/s41598-018-25168-3, PubMed 29712976
5. Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Trøseid M (2018)
   Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
   J Am Coll Cardiol, 71 (10), 1184-1186
   DOI 10.1016/j.jacc.2017.12.057, PubMed 29519360
6. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
   Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
   ESC Heart Fail, 5 (5), 977-984
   DOI 10.1002/ehf2.12332, PubMed 30088346
7. Missailidis C, Neogi U, Stenvinkel P, Trøseid M, Nowak P, Bergman P (2018)
   The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages
   AIDS, 32 (12), 1589-1598
   DOI 10.1097/QAD.0000000000001813, PubMed 29620717
8. Troseid M, Nordoy I, Fevang B, Aukrust P (2018)
   Tenders for HIV medicines are not academically justified
   Tidsskr. Nor. Laegeforen., 138 (20), 1912-1913
9. Trøseid M, Nordøy I, Fevang B, Aukrust P (2018)
   [Tendering for HIV drugs is not clinically justified]
   Tidsskr Nor Laegeforen, 138 (20)
   DOI 10.4045/tidsskr.18.0808, PubMed 30539614

Publications 2017

1. Gelpi M, Hartling HJ, Ueland PM, Ullum H, Trøseid M, Nielsen SD (2017)
   Tryptophan catabolism and immune activation in primary and chronic HIV infection
   BMC Infect Dis, 17 (1), 349
   DOI 10.1186/s12879-017-2456-z, PubMed 28511640
2. Haissman JM, Haugaard AK, Ostrowski SR, Berge RK, Hov JR, Trøseid M, Nielsen SD (2017)
   Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
   BMC Infect Dis, 17 (1), 445
   DOI 10.1186/s12879-017-2547-x, PubMed 28645263
3. Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
   HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
   BMC Infect Dis, 17 (1), 234
   DOI 10.1186/s12879-017-2334-8, PubMed 28356058
4. Hovland A, Nestvold T, Bohov P, Trøseid M, Aukrust P, Berge RK, Waage-Nielsen E, Retterstøl K, Lappegård KT (2017)
   Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
   Scand J Clin Lab Invest, 77 (8), 628-633
   DOI 10.1080/00365513.2017.1393691, PubMed 29069988
5. Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Trøseid M (2017)
   Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
   J Card Fail, 23 (9), 666-671
   DOI 10.1016/j.cardfail.2017.06.007, PubMed 28688889
6. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
   Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
   PLoS One, 12 (5), e0176527
   DOI 10.1371/journal.pone.0176527, PubMed 28464042
7. Trøseid M (2017)
   Gut microbiota and acute coronary syndromes: ready for use in the emergency room?
   Eur Heart J, 38 (11), 825-827
   DOI 10.1093/eurheartj/ehx005, PubMed 28159962

Publications 2016

1. Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
   Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
   J Acquir Immune Defic Syndr, 73 (5), 507-513
   DOI 10.1097/QAI.0000000000001148, PubMed 27509250
2. Haissman JM, Knudsen A, Hoel H, Kjær A, Kristoffersen US, Berge RK, Katzenstein TL, Svardal A, Ueland T, Aukrust P, Lebech AM, Nielsen SD, Trøseid M (2016)
   Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection
   J Acquir Immune Defic Syndr, 71 (2), 130-6
   DOI 10.1097/QAI.0000000000000843, PubMed 26413854
3. Jespersen S, Pedersen KK, Anesten B, Zetterberg H, Fuchs D, Gisslén M, Hagberg L, Trøseid M, Nielsen SD (2016)
   Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
   BMC Infect Dis, 16, 176
   DOI 10.1186/s12879-016-1510-6, PubMed 27103116
4. Jortveit J, Dahlslett T, Kvien EH, Lundblad R, Trøseid M, Beitnes JO (2016)
   [A man in his 20s with abdominal pain and heart murmurs]
   Tidsskr Nor Laegeforen, 136 (3), 238-40
   DOI 10.4045/tidsskr.15.0790, PubMed 26860384
5. Jørgensen SF, Trøseid M, Kummen M, Anmarkrud JA, Michelsen AE, Osnes LT, Holm K, Høivik ML, Rashidi A, Dahl CP, Vesterhus M, Halvorsen B, Mollnes TE, Berge RK, Moum B, Lundin KE, Fevang B, Ueland T, Karlsen TH, Aukrust P, Hov JR (2016)
   Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
   Mucosal Immunol, 9 (6), 1455-1465
   DOI 10.1038/mi.2016.18, PubMed 26982597
6. Knudsen A, Christensen TE, Thorsteinsson K, Ghotbi AA, Hasbak P, Lebech AM, Nielsen SD, Hov JR, Berge R, Ripa RS, Kjær A, Trøseid M (2016)
   Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT
   J Acquir Immune Defic Syndr, 72 (4), e83-5
   DOI 10.1097/QAI.0000000000001044, PubMed 27152465
7. Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR (2016)
   The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
   Gut, 66 (4), 611-619
   DOI 10.1136/gutjnl-2015-310500, PubMed 26887816
8. Kummen M, Vesterhus M, Trøseid M, Moum B, Svardal A, Boberg KM, Aukrust P, Karlsen TH, Berge RK, Hov JR (2016)
   Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
   United European Gastroenterol J, 5 (4), 532-541
   DOI 10.1177/2050640616663453, PubMed 28588885
9. Skagen K, Trøseid M, Ueland T, Holm S, Abbas A, Gregersen I, Kummen M, Bjerkeli V, Reier-Nilsen F, Russell D, Svardal A, Karlsen TH, Aukrust P, Berge RK, Hov JE, Halvorsen B, Skjelland M (2016)
   The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis
   Atherosclerosis, 247, 64-9
   DOI 10.1016/j.atherosclerosis.2016.01.033, PubMed 26868510
10. Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
    J Acquir Immune Defic Syndr, 73 (2), 138-48
    DOI 10.1097/QAI.0000000000001080, PubMed 27632144
11. Trøseid M, Hov JR, Nestvold TK, Thoresen H, Berge RK, Svardal A, Lappegård KT (2016)
    Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery
    Metab Syndr Relat Disord, 14 (4), 197-201
    DOI 10.1089/met.2015.0120, PubMed 27081744

Publications 2015

1. Hartling HJ, Birch C, Gaardbo JC, Hove M, Trøseid M, Clausen MR, Gerstoft J, Ullum H, Nielsen SD (2015)
   T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen
   APMIS, 123 (10), 903-11
   DOI 10.1111/apm.12429, PubMed 26279289
2. Hov JE, Trøseid M (2015)
   Personalised medicine targeting the gut microbiota?
   Tidsskr Nor Laegeforen, 135 (7), 624
   DOI 10.4045/tidsskr.14.1431, PubMed 25899345
3. Hov JER, Troseid M (2015)
   Personalized intestinal flora medicine?
   Tidsskr. Nor. Laegeforen., 135 (7), 624
4. Nowak P, Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, Hov JR, Noyan K, Vesterbacka J, Svärd J, Rudi K, Sönnerborg A (2015)
   Gut microbiota diversity predicts immune status in HIV-1 infection
   AIDS, 29 (18), 2409-18
   DOI 10.1097/QAD.0000000000000869, PubMed 26355675
5. Pedersen KK, Eiersted MR, Gaardbo JC, Pedersen M, Gerstoft J, Troseid M, Nielsen SD (2015)
   Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared With Healthy Controls
   J Acquir Immune Defic Syndr, 70 (1), 16-22
   DOI 10.1097/QAI.0000000000000697, PubMed 26017659
6. Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
   Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
   J Acquir Immune Defic Syndr, 70 (4), 329-37
   DOI 10.1097/QAI.0000000000000784, PubMed 26258571
7. Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AEA, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Troseid M (2015)
   Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
   JAIDS, 70 (4), 329-337
8. Troseid M (2015)
   [Antiretroviral drugs against HIV infections]
   Tidsskr Nor Laegeforen, 135 (11), 1054
   DOI 10.4045/tidsskr.15.0156, PubMed 26080783
9. Troseid M (2015)
   AIDS epidemic Defeats, victories and new challenges
   Tidsskr. Nor. Laegeforen., 135 (11), 1059
   DOI 10.4045/tidsskr.15.0533
10. Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
    Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
    Metab Syndr Relat Disord, 13 (3), 119-24
    DOI 10.1089/met.2014.0111, PubMed 25562385

Publications 2014

1. Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
   A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
   PLoS One, 9 (1), e85604
   DOI 10.1371/journal.pone.0085604, PubMed 24416431
2. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
   Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
   J Acquir Immune Defic Syndr, 65 (4), e158-61
   DOI 10.1097/QAI.0000000000000055, PubMed 24577189
3. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Troseid M (2014)
   Monocyte Activation, but not Microbial Translocation, Is Independently Associated With Markers of Endovascular Dysfunction in HIV-Infected Patients Receiving cART
   JAIDS, 67 (4), 370-374
4. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
   Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
   J Acquir Immune Defic Syndr, 67 (4), 370-4
   DOI 10.1097/QAI.0000000000000339, PubMed 25226210
5. Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
   Antiretroviral treatment failure predicts mortality in rural Tanzania
   Int J STD AIDS, 26 (9), 633-9
   DOI 10.1177/0956462414548460, PubMed 25122578
6. Trøseid M, Ditlevsen S, Hvid T, Gerstoft J, Grøndahl T, Pedersen BK, Nielsen SD, Lindegaard B (2014)
   Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals
   J Acquir Immune Defic Syndr, 66 (2), e52-4
   DOI 10.1097/QAI.0000000000000132, PubMed 24608893
7. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
   Microbial translocation and cardiometabolic risk factors in HIV infection
   AIDS Res Hum Retroviruses, 30 (6), 514-22
   DOI 10.1089/aid.2013.0280, PubMed 24521167
8. Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
   Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
   J Intern Med, 277 (6), 717-26
   DOI 10.1111/joim.12328, PubMed 25382824

Publications 2013

1. Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
   Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
   PLoS One, 8 (7), e69896
   DOI 10.1371/journal.pone.0069896, PubMed 23875007
2. Haugaard AK, Lund TT, Birch C, Rönsholt F, Trøseid M, Ullum H, Gerstoft J, Johansson PI, Nielsen SD, Ostrowski SR (2013)
   Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation
   AIDS, 27 (17), 2749-58
   DOI 10.1097/01.aids.0000432462.21723.ed, PubMed 23842126
3. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
   Markers of microbial translocation predict hypertension in HIV-infected individuals
   HIV Med, 14 (6), 354-61
   DOI 10.1111/hiv.12015, PubMed 23332095
4. Pedersen KK, Pedersen M, Troseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
   Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction
   JAIDS, 64 (5), 425-433
5. Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
   Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
   J Acquir Immune Defic Syndr, 64 (5), 425-33
   DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
6. Trøseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegård KT (2013)
   Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery
   Diabetes Care, 36 (11), 3627-32
   DOI 10.2337/dc13-0451, PubMed 23835694

Publications 2012

1. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
   Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
   J Clin Hypertens (Greenwich), 15 (2), 101-6
   DOI 10.1111/jch.12029, PubMed 23339727
2. Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
   Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
   Int J Microbiol, 2012, 263836
   DOI 10.1155/2012/263836, PubMed 22719767
3. Nowak P, Nystrom J, Troseid M (2012)
   High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
   Anticancer Res, 32 (9), 4067-9
   PubMed 22993362
4. Nowak P, Nystrom J, Troseid M (2012)
   High Levels of HMGB1 in Plasma May Be due to Ex Vivo Cell Necrosis
   Anticancer Res., 32 (9), 4067-4069
5. Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
   Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
   Innate Immun, 19 (3), 290-7
   DOI 10.1177/1753425912461042, PubMed 23070967

Publications 2011

1. Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
   p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
   Int J STD AIDS, 22 (12), 719-21
   DOI 10.1258/ijsa.2009.009382, PubMed 22174052
2. Trøseid M (2011)
   [The fight against HIV--two scenarios]
   Tidsskr Nor Laegeforen, 131 (23), 2331
   DOI 10.4045/tidsskr.11.1213, PubMed 22139097
3. Trøseid M, Sönnerborg A, Nowak P (2011)
   High mobility group box protein-1 in HIV-1 infection
   Curr HIV Res, 9 (1), 6-10
   DOI 10.2174/157016211794582632, PubMed 21198433
4. Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
   Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
   Wien Klin Wochenschr, 123 (21-22), 650-4
   DOI 10.1007/s00508-011-0028-6, PubMed 21842238

Publications 2010

1. Trøseid M, Johannessen A (2010)
   [The battle against HIV can be won, but there is not enough money!]
   Tidsskr Nor Laegeforen, 130 (16), 1599-600
   DOI 10.4045/tidsskr.10.0705, PubMed 20805855
2. Trøseid M, Johannessen A (2010)
   [A step in the right direction]
   Tidsskr Nor Laegeforen, 130 (22), 2223
   DOI 10.4045/tidsskr.10.1100, PubMed 21109841
3. Trøseid M, Nowak P, Nyström J, Lindkvist A, Abdurahman S, Sönnerborg A (2010)
   Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy
   AIDS, 24 (11), 1733-7
   DOI 10.1097/QAD.0b013e32833b254d, PubMed 20502315
4. Trøseid M, Seljeflot I, Arnesen H (2010)
   The role of interleukin-18 in the metabolic syndrome
   Cardiovasc Diabetol, 9, 11
   DOI 10.1186/1475-2840-9-11, PubMed 20331890
5. Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
   Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
   Thromb Haemost, 103 (3), 679-81
   DOI 10.1160/TH09-05-0317, PubMed 20076844
6. Weiss TW, Schumacher S, Kaun C, Katsaros KM, Trøseid M, Huber K, Maurer G, Wojta J (2010)
   Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes
   Swiss Med Wkly, 140, w13105
   DOI 10.4414/smw.2010.13105, PubMed 20927683

Publications 2009

1. Johannessen A, Trøseid M, Calmy A (2009)
   Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings
   J Antimicrob Chemother, 64 (6), 1126-9
   DOI 10.1093/jac/dkp353, PubMed 19776036
2. Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
   Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
   Metabolism, 58 (11), 1543-9
   DOI 10.1016/j.metabol.2009.04.031, PubMed 19595382
3. Trøseid M, Eskesen A, Bruun JN (2009)
   [Immune reconstitution inflammatory syndrome and treatment of HIV infection]
   Tidsskr Nor Laegeforen, 129 (23), 2484-7
   DOI 10.4045/tidsskr.09.0190, PubMed 19997137
4. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
   The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
   Metab Syndr Relat Disord, 7 (6), 579-84
   DOI 10.1089/met.2009.0003, PubMed 19900154
5. Trøseid M, Seljeflot I, Weiss TW, Klemsdal TO, Hjerkinn EM, Arnesen H (2009)
   Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome
   Atherosclerosis, 209 (2), 337-9
   DOI 10.1016/j.atherosclerosis.2009.09.028, PubMed 19836750

Publications 2008

1. Trøseid M (2008)
   [Children with HIV--still a big challenge]
   Tidsskr Nor Laegeforen, 128 (8), 952-3
   PubMed 18459190
2. Trøseid M, Seljeflot I, Hjerkinn EM, Arnesen H (2008)
   Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia
   Diabetes Care, 32 (3), 486-92
   DOI 10.2337/dc08-1710, PubMed 19092166
3. Trøseid M, Steinbakk M (2008)
   [Whooping cough vaccination should be re-evaluated]
   Tidsskr Nor Laegeforen, 128 (2), 204
   PubMed 18202739

Publications 2007

1. Trøseid M, Handal N, Holen Ø (2007)
   [Tuberculosis--the forgotten part of the HIV epidemic]
   Tidsskr Nor Laegeforen, 127 (20), 2712-4
   PubMed 17952165

Publications 2006

1. Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M (2006)
   [Whooping cough--an increasing problem in Norway]
   Tidsskr Nor Laegeforen, 126 (3), 305-8
   PubMed 16440035
2. Trøseid M (2006)
   [Antiretroviral therapy in Poipet]
   Tidsskr Nor Laegeforen, 126 (17), 2290-2
   PubMed 16967084
3. Trøseid M, Hjerkinn EM, Seljeflot I, Klemsdal TO, Bergengen L, Breivik L, Arnesen H (2006)
   Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly men
   Scand J Clin Lab Invest, 66 (2), 137-45
   DOI 10.1080/00365510500474462, PubMed 16537247

Publications 2005

1. Trøseid M, Henriksen OA, Lindal S (2005)
   Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family
   APMIS, 113 (9), 635-7
   DOI 10.1111/j.1600-0463.2005.apm_270.x, PubMed 16218940
2. Trøseid M, Jonassen TØ, Steinbakk M (2005)
   Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma
   J Infect, 52 (1), e11-3
   DOI 10.1016/j.jinf.2005.04.014, PubMed 15936087
3. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2005)
   Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome
   Scand J Clin Lab Invest, 65 (4), 283-90
   DOI 10.1080/00365510510013811, PubMed 16076683

Publications 2004

1. Trøseid M, Lappegård KT, Claudi T, Damås JK, Mørkrid L, Brendberg R, Mollnes TE (2004)
   Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome
   Eur Heart J, 25 (4), 349-55
   DOI 10.1016/j.ehj.2003.12.006, PubMed 14984925

Publications 2002

1. Trøseid M (2002)
   [Reduced use of restricted-prescription preparations in general practice]
   Tidsskr Nor Laegeforen, 122 (5), 482-3
   PubMed 11961975

Publications 1999

1. Trøseid M, Gerlyng P (1999)
   [Parvovirus B19 as a cause of acute arthritis]
   Tidsskr Nor Laegeforen, 119 (23), 3415-6
   PubMed 10553337

Publications 1997

1. Sømme S, Trøseid M (1997)
   [Being a medical student in Michigan]
   Tidsskr Nor Laegeforen, 117 (19), 2828-9
   PubMed 9312879